| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2005 | 2014 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2005 | 2014 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.500 | None | 1.000 | 2 | 0 | 2003 | 2014 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.500 | None | 1.000 | 3 | 0 | 2003 | 2018 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 2008 | 2013 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
disease | 0.500 | None | 1.000 | 2 | 0 | 2003 | 2010 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
disease | 0.500 | None | 1.000 | 2 | 0 | 2004 | 2017 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2012 | 2014 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
leptin | 0.349 | 0.846 | 0.46 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2003 | 2018 | ||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 2009 | 2012 | ||||||||
|
toll like receptor 2 | 0.361 | 0.923 | 1.0E-06 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
disease | 0.500 | None | 1.000 | 2 | 0 | 1999 | 2008 | ||||||||
|
fibronectin 1 | 0.365 | 0.962 | 1.4E-03 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 2005 | 2010 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
disease | 0.500 | None | 1.000 | 2 | 0 | 2007 | 2008 | ||||||||
|
mitogen-activated protein kinase 3 | 0.379 | 0.885 | 3.7E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
TIMP metallopeptidase inhibitor 1 | 0.380 | 0.885 | 0.50 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 1996 | 2014 |